CIPLA vs DRREDDY: Which Is Better on the Numbers?

Cipla Ltd (CIPLA) trades at ₹1415 on a P/E of 30.4, while Dr Reddys Laboratories Ltd (DRREDDY) trades at ₹1183 on a P/E of 25.1. On valuation, Dr Reddys Laboratories Ltd is cheaper on earnings (P/E 25.1 vs 30.4). This is a data comparison, not a recommendation.

Cipla Ltd

CIPLA
₹1,415.1

Dr Reddys Laboratories Ltd

DRREDDY
₹1,182.8

CIPLA vs DRREDDY - full comparison

MetricCIPLADRREDDY
Share price₹1,415.1₹1,182.8
P/E ratio (lower = cheaper)30.4025.10
ROE (higher = better)11.60%11.20%
ROCE (higher = better)15.50%13.00%
Dividend yield0.91%0.66%
Annualised return (history)-2.6%-6.8%
Volatility (lower = steadier)22%22%
1-year forecast (Monte Carlo median)₹1,345.1₹1,081.1
Cheapest MTF margin22% (Dhan)22% (Dhan)

Forecast as of 22 Jul

How CIPLA and DRREDDY compare

Not investment advice. This page compares publicly available metrics and a statistical forecast for information only. The 1-year forecast is a Monte Carlo projection from historical volatility, not a prediction. Do your own research or consult a SEBI-registered adviser before investing.

More stock comparisons

Related tools